Founded in 2011, OncoStem operates in Health Tech industry. Initially focused on offering diagnostic tests for breast cancer, the company has expanded its scope to address other cancers using its prop...
Funding stage:
Series A
Last funding:
05/09/2017
Total funding:
$6.00 Mn+
Revenue:
Investors
Employee count:
22
Last 90d
22
Last 90d
Web traffic:
806
806
Last 30d
Last 30d
Glassdoor Rating:
OncoStem: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date30 March 2023- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of OncoStem
As of 31 March 2023, OncoStem's equity is held by 3 shareholders, with the top three being OncoStem Diagnostics Mauritius Private Limited, OncoStem Pte Limited Singapore, and AVLP Mauritius Private Limited.
OncoStem Diagnostics Mauritius Private Limited holds the largest stake in OncoStem at 98.0% as of 31 March 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links